Published in Dtsch Med Wochenschr on May 16, 1975
Mitochondrial antibodies in chronic liver diseases and connective tissue disorders: further characterization of the autoantigens. Clin Exp Immunol (1980) 1.66
Heterogeneity of anti-mitochondrial antibodies: characterization and separation of the antigen associated with the pseudolupus erythematosus syndrome. Clin Exp Immunol (1979) 1.27
Clinical significance of immunopathological findings in patients with post-pericardiotomy syndrome. I. Relevance of antibody pattern. Clin Exp Immunol (1979) 1.25
Haemagglutinating anti-actin antibodies in acute and chronic liver disease. Gut (1980) 0.81
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol (1999) 9.11
Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med (2000) 4.13
Large-cell anaplastic lymphoma-specific translocation (t[2;5] [p23;q35]) in Hodgkin's disease: indication of a common pathogenesis? Lancet (1995) 3.56
Acute myocardial infarction in women: influence of gender on mortality and prognostic variables. Am J Cardiol (1988) 2.42
Mitochondrial antibodies in primary biliary cirrhosis. I. Localization of the antigen to mitochondrial membranes. J Exp Med (1967) 2.09
Toxic hepatitis by clozapine treatment. Am J Psychiatry (1993) 1.83
The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome. J Clin Endocrinol Metab (2001) 1.82
Accuracy and feasibility of contrast echocardiography for detection of perfusion defects in routine practice: comparison with wall motion and technetium-99m sestamibi single-photon emission computed tomography. The Nycomed NC100100 Investigators. J Am Coll Cardiol (1998) 1.64
Vaccination against hydatidosis using a defined recombinant antigen. Parasite Immunol (1996) 1.63
Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. Gut (1992) 1.60
Kinetics of the graft-versus-leukemia response after donor leukocyte infusions for relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation. Blood (1998) 1.59
[Lupus erythematosus-like syndrome with antimitochondrial antibodies]. Dtsch Med Wochenschr (1973) 1.58
Assessment of myocardial injury by serum tumour necrosis factor alpha measurements in acute myocardial infarction. Eur Heart J (1996) 1.54
Morphometric studies of the entorhinal cortex in neuropsychiatric patients and controls: clusters of heterotopically displaced lamina II neurons are not indicative of schizophrenia. Schizophr Res (1998) 1.53
Outlook after acute myocardial infarction in the very elderly compared with that in patients aged 65 to 75 years. J Am Coll Cardiol (1990) 1.52
ATPase-associated antigen (M2): marker antigen for serological diagnosis of primary biliary cirrhosis. Lancet (1982) 1.49
Influence of right bundle branch block on short- and long-term survival after acute anterior myocardial infarction. J Am Coll Cardiol (1991) 1.49
"Autoallergic" hepatitis. N Engl J Med (1970) 1.46
Cardiovascular and renal haemodynamic effects of dopexamine: comparison with dopamine. Br J Anaesth (1990) 1.46
Non-organ-specific cytoplasmic antibodies detected by immunofluorescence. Int Arch Allergy Appl Immunol (1971) 1.46
Demonstration of organ specific antibodies against heart mitochondria (anti-M7) in sera from patients with some forms of heart diseases. Clin Exp Immunol (1984) 1.46
Mitochondrial antibodies in primary biliary cirrhosis. 3. Characterization of the inner-membrane complement fixing antigen. Clin Exp Immunol (1969) 1.45
Eosinophilia-myalgia syndrome in Germany: an epidemiologic review. Mayo Clin Proc (1994) 1.44
Mitochondrial antibodies in primary biliary cirrhosis: species and nonspecies specific determinants of M2 antigen. Hepatology (1985) 1.43
Influence of right bundle branch block on short- and long-term survival after inferior wall Q-wave myocardial infarction. Am J Cardiol (1991) 1.41
A decision scheme for coronary angiography after acute myocardial infarction. Circulation (1989) 1.39
Mitochondrial antibodies in primary biliary cirrhosis. IV. Significance of membrane structure for the complement-fixing antigen. Immunology (1969) 1.35
The complex nature of mitochondrial antibodies and their relation to primary biliary cirrhosis. Semin Liver Dis (1981) 1.33
Serial measurements of left ventricular ejection fraction by radionuclide angiography early and late after myocardial infarction. Am J Cardiol (1976) 1.32
Heterogeneity of anti-mitochondrial antibodies: characterization and separation of the antigen associated with the pseudolupus erythematosus syndrome. Clin Exp Immunol (1979) 1.27
Influence of heart rate on mortality after acute myocardial infarction. Am J Cardiol (1990) 1.25
Clinical significance of immunopathological findings in patients with post-pericardiotomy syndrome. I. Relevance of antibody pattern. Clin Exp Immunol (1979) 1.25
Differing circadian patterns of symptom onset in subgroups of patients with acute myocardial infarction. Circulation (1989) 1.24
Endocarditis and aortal embolization caused by Aspergillus terreus in a patient with acute lymphoblastic leukemia in remission: diagnosis by peripheral-blood culture. J Clin Microbiol (1998) 1.24
Diagnostic relevance of humoral and cell-mediated immune reactions in patients with acute viral myocarditis. Clin Exp Immunol (1982) 1.23
Mitochondrial antibodies in primary biliary cirrhosis. II. The complement fixing antigen as a component of mitochondrial inner membranes. Br J Exp Pathol (1969) 1.22
Antimitochondrial antibodies in primary biliary cirrhosis. J Hepatol (1986) 1.22
Approach to the estimation of myocardial infarct size by analysis of precordial S-T segment and R wave maps. Am J Cardiol (1978) 1.22
Clinical significance of mitochondrial antibodies in relation to liver disease. Lancet (1981) 1.21
Reverse signaling through transmembrane TNF confers resistance to lipopolysaccharide in human monocytes and macrophages. J Immunol (2000) 1.21
Histopathological features in mixed types of chronic aggressive hepatitis and primary biliary cirrhosis. Correlations of liver histology with mitochondrial antibodies of different specificity. Virchows Arch A Pathol Anat Histol (1977) 1.20
Myocardial infarction in young patients: an analysis by age subsets. Circulation (1986) 1.19
[Limitations and hazards of percutaneous liver biopsy with the Menghini needle. Experiences with 80,000 liver biopsies]. Dtsch Med Wochenschr (1967) 1.18
Mitochondrial antibodies in primary biliary cirrhosis. VI. Association of the complement fixing antigen with a component of the mitochondrial F1-ATPase complex. Clin Exp Immunol (1982) 1.17
In vivo phosphorylation of histone H1 variants during the cell cycle. Biochemistry (1996) 1.12
Limitations and advantages of the ejection fraction for defining high risk after acute myocardial infarction. Am J Cardiol (1986) 1.11
Prophylactic sclerotherapy for esophageal varices: long-term results of a prospective study. Endoscopy (1994) 1.11
Effects of reagent and enzymatically generated hypochlorite on physicochemical and metabolic properties of high density lipoproteins. J Biol Chem (1997) 1.11
Human heart-type fatty-acid-binding protein as a point-of-care test in the early diagnosis of acute myocardial infarction. QJM (2007) 1.10
Hepatic zinc content in patients with various stages of alcoholic liver disease and in patients with chronic active and chronic persistent hepatitis. Hepatology (1988) 1.10
Significance and specificity of antibodies to neutrophils detected by western blotting for the serological diagnosis of primary sclerosing cholangitis. Hepatology (1991) 1.10
Effects of clozapine on in vitro immune parameters: a longitudinal study in clozapine-treated schizophrenic patients. Neuropsychopharmacology (1998) 1.07
Disposition of diazepam and its major metabolite desmethyldiazepam in patients with liver disease. Clin Pharmacol Ther (1977) 1.07
Left ventricular performance assessed by radionuclide angiocardiography and echocardiography in patients with previous myocardial infarction. Circulation (1975) 1.06
Adipocyte plasma membranes contain two Gi subtypes but are devoid of Go. FEBS Lett (1988) 1.06
Short- and long-term clinical outcome after Q wave and non-Q wave myocardial infarction in a large patient population. Circulation (1989) 1.05
Smoking status at the time of acute myocardial infarction and subsequent prognosis. Am Heart J (1985) 1.04
[Immunologic phenomena in liver diseases: significance of mitochondrial antibodies]. Klin Wochenschr (1969) 1.04
Prognosis after acute myocardial infarction: a multivariate analysis of mortality and survival. Circulation (1979) 1.03
Room temperature activates human blood platelets. Lab Invest (2001) 1.02
Multicentre randomized therapeutic trial for advanced centrocytic lymphoma: anthracycline does not improve the prognosis. Hematol Oncol (1989) 1.02
[Mitochondrial antibodies in nonhepatic diseases. Occurrence, significance and differential diagnosis]. Dtsch Med Wochenschr (1973) 1.02
Development of adrenocortical failure in non-Addisonian patients with antibodies to adrenal cortex. A clinical follow-up study. Clin Endocrinol (Oxf) (1982) 1.02
Serology of primary biliary cirrhosis. Springer Semin Immunopathol (1980) 1.02
The power-consumption-controlled extruder: a tool for pellet production. J Pharm Pharmacol (1994) 1.00
Nitric oxide synthase-containing neurons in the human hypothalamus: reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics. Neuroscience (1998) 1.00
Isolated endocarditis of the pulmonary valve caused by Pasteurella multocida. Infection (2007) 1.00
Immunology of primary biliary cirrhosis. Baillieres Clin Gastroenterol (1987) 0.99
Characterization and clinical relevance of liver-pancreas antibodies in autoimmune hepatitis. Hepatology (1993) 0.98
[Hereditary and non-hereditary form of chronic hepatic porphyria: different behaviour of uroporphyrinogen decarboxylase in liver and erythrocytes (author's transl)]. Klin Wochenschr (1980) 0.98
Hyperphosphorylation of histone H2A.X and dephosphorylation of histone H1 subtypes in the course of apoptosis. Cell Death Differ (2002) 0.98
Anti-mitochondrial antibodies in patients with dilated cardiomyopathy (anti-M7) are directed against flavoenzymes with covalently bound FAD. Clin Exp Immunol (1998) 0.97
Prediction of late mortality after myocardial infarction from variables measured at different times during hospitalization. Am J Cardiol (1984) 0.97
Rearranged Ig heavy chain DNA is detectable in cell-free blood samples of patients with B-cell neoplasia. Blood (1997) 0.96
Dual myocardial imaging with technetium-99m pyrophosphate and thallium-201 for detecting, localizing and sizing acute myocardial infarction. Am J Cardiol (1977) 0.96
Right ventricular ejection fraction in patients with acute anterior and inferior myocardial infarction assessed by radionuclide angiography. Circulation (1978) 0.96
Clinical and prognostic relevance of different mitochondrial antibody profiles in primary biliary cirrhosis (PBC). Mol Aspects Med (1985) 0.95
Influence of obesity on morbidity and mortality after acute myocardial infarction. Am Heart J (1987) 0.95
In vitro binding of H1 histone subtypes to nucleosomal organized mouse mammary tumor virus long terminal repeat promotor. J Biol Chem (1998) 0.95
Mitochondrial antigens and autoantibodies: from anti-M1 to anti-M9. Klin Wochenschr (1986) 0.95
Lipoprotein-associated alpha-tocopheryl-succinate inhibits cell growth and induces apoptosis in human MCF-7 and HBL-100 breast cancer cells. Biochim Biophys Acta (2000) 0.95
The essential transfer protein TraM binds to DNA as a tetramer. J Biol Chem (1999) 0.94
Characterization and clinical relevance of a new complement-fixing antibody--anti-M8--in patients with primary biliary cirrhosis. Hepatology (1986) 0.94
[Chronic active (aggressive) hepatitis. Differential diagnosis of lupoid (ANA-positive) and cholestatic (AMA-positive) hepatitis]. Dtsch Med Wochenschr (1976) 0.94
Long-term outcome in patients with inferior myocardial infarction and complete atrioventricular block. J Am Coll Cardiol (1988) 0.94
Histone separation by high-performance liquid chromatography on C4 reverse-phase columns. Anal Biochem (1986) 0.93
[Wegener's granulomatosis: otologic and clinico-immunologic aspects]. Laryngorhinootologie (1992) 0.92
Cytokine expression in T-cell lymphomas and Hodgkin's disease. Its possible implication in autocrine or paracrine production as a potential basis for neoplastic growth. Am J Pathol (1991) 0.92
Characterization of a new mitochondrial antigen-antibody system (M9/anti-M9) in patients with anti-M2 positive and anti-M2 negative primary biliary cirrhosis. Clin Exp Immunol (1988) 0.92
Determination of total polar parts with new methods for the quality survey of frying fats and oils. Talanta (1998) 0.92
Influence on prognosis and morbidity of left ventricular ejection fraction with and without signs of left ventricular failure after acute myocardial infarction. Am J Cardiol (1988) 0.92
NADP efficiently inhibits endogenous but not pertussis toxin-catalyzed covalent modification of membrane proteins incubated with NAD. FEBS Lett (1987) 0.92
First myocardial infarction: age and ejection fraction identify a low-risk group. Am Heart J (1988) 0.91
Sera from patients with tuberculosis recognize the M2a-epitope (E2-subunit of pyruvate dehydrogenase) specific for primary biliary cirrhosis. Clin Exp Immunol (1993) 0.91
Diabetic patients and beta-blockers after acute myocardial infarction. Eur Heart J (1990) 0.90
[Options and limits of visual function tests available on the internet]. Ophthalmologe (2002) 0.90
The importance of variant insertions of the ligamentum teres hepatis in the Cruveilhier-Baumgarten syndrome. Endoscopy (1988) 0.90